Yale: Lower Dose of COVID-19 Drug is Effective - Allows Treatment for More
March 24, 2022
March 24, 2022
NEW HAVEN, Connecticut, March 24 (TNSJou) -- Yale University issued the following news:
Many countries around the world are experiencing shortages of tocilizumab, an immunosuppressive drug that has become the standard of care for treating severe cases of COVID-19. A new study co-led by researchers at Yale and the University of British Columbia, however, finds that using a lower dose of tocilizumab than has been standard is also effective in treating severe cases, and allows up to tw . . .
Many countries around the world are experiencing shortages of tocilizumab, an immunosuppressive drug that has become the standard of care for treating severe cases of COVID-19. A new study co-led by researchers at Yale and the University of British Columbia, however, finds that using a lower dose of tocilizumab than has been standard is also effective in treating severe cases, and allows up to tw . . .